glp-1 liver Current status of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatotic disease: A clinical perspective Emerging Role of GLP-1 Receptor

Nonalcoholic steatohepatitis (NASH), as a severe form of nonalcoholic fatty liver disease (NAFLD), is characterized by liver steatosis, inflammation, hepatocellular injury and different degrees of fibrosis

Learn how dehydration, weight loss, and side effects may affect kidney health, plus prevention tips.

Pendulum Metabolic Daily | Optimizes metabolism Pendulum Akkermansia | For gut health Pendulum Glucose Control | For A1C management

Tirzepatide 15 mg led to higher discontinuation rate of study medication due to adverse events regardless of comparator, while all tirzepatide doses were safe in terms of serious adverse events and mortality

Ohio's GLP-1 coverage fractured in 2025-2026 State of Ohio employee plan, OSU Health Plan, and Ohio Medicaid all narrowed weight-loss GLP-1 access

Beverly Hills medical weight loss clinic offering GLP-1 therapy, semaglutide, weight loss injections, and physician-supervised programs